CTNM
Contineum Therapeutics, Inc.
Company overview
- Market capitalization
- $294.05M
- Employees
- 51
- Latest publication
- 2026-09-29
About Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 242,000USD | 0USD | 0USD |
| Cost Of Revenue | 83,000USD | 85,000USD | 81,000USD | 79,000USD | — | 121,000USD | — | 60,000USD |
| Gross Profit | -83,000USD | -85,000USD | -81,000USD | -79,000USD | — | 121,000USD | — | -60,000USD |
| Research Development | 11,648,000USD | 12,755,000USD | 10,992,000USD | 13,984,000USD | 13,712,000USD | 13,015,000USD | 9,728,000USD | 7,901,000USD |
| Selling General Administrative | 5,256,000USD | 4,360,000USD | 3,940,000USD | 3,839,000USD | 4,398,000USD | 4,032,000USD | 3,246,000USD | 3,043,000USD |
| Total Operating Expenses | 16,904,000USD | 17,115,000USD | 14,932,000USD | 17,823,000USD | 18,110,000USD | -84,741,000USD | 12,974,000USD | 10,944,000USD |
| Operating Income | -16,904,000USD | -17,115,000USD | -14,932,000USD | -17,902,000USD | -18,110,000USD | 84,741,000USD | -12,974,000USD | -10,944,000USD |
| Interest Income | 2,505,000USD | 2,010,000USD | 1,957,000USD | 2,029,000USD | 2,250,000USD | 2,528,000USD | 2,741,000USD | 2,001,000USD |
| Net Interest Income | 2,505,000USD | 2,010,000USD | 1,957,000USD | 2,029,000USD | 2,250,000USD | 2,528,000USD | 2,741,000USD | 2,001,000USD |
| Income Before Tax | -14,456,000USD | -15,156,000USD | -12,792,000USD | -16,040,000USD | -15,990,000USD | -14,565,000USD | -10,267,000USD | -9,009,000USD |
| Net Income | -14,456,000USD | -15,156,000USD | -12,792,000USD | -16,040,000USD | -15,990,000USD | -14,565,000USD | -10,267,000USD | -9,009,000USD |
| Net Income From Continuing Ops | -14,456,000USD | -15,156,000USD | -12,792,000USD | -16,040,000USD | -15,990,000USD | -14,565,000USD | -10,267,000USD | -9,009,000USD |
| Ebit | -14,456,000USD | -15,156,000USD | -12,792,000USD | -16,040,000USD | -15,990,000USD | -14,565,000USD | -10,267,000USD | -9,009,000USD |
| Ebitda | -14,373,000USD | -15,071,000USD | -12,711,000USD | -15,961,000USD | -15,912,000USD | -14,490,000USD | -10,205,000USD | -8,949,000USD |
| Depreciation And Amortization | 83,000USD | 85,000USD | 81,000USD | 79,000USD | 78,000USD | 75,000USD | 62,000USD | 60,000USD |
| Reconciled Depreciation | 83,000USD | 85,000USD | 81,000USD | 79,000USD | 78,000USD | 75,000USD | 62,000USD | 60,000USD |
| Total Other Income Expense Net | 2,448,000USD | 1,959,000USD | 2,140,000USD | 1,862,000USD | 2,120,000USD | -99,306,000USD | 2,707,000USD | 1,935,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -101,788,000USD | — | — |
| Interest Expense | — | — | — | — | — | 0USD | 0USD | 0USD |
| Tax Provision | — | — | — | — | — | 0USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 60,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 50,000,000USD | 0USD | 0USD |
| Cost Of Revenue | 323,000USD | 258,000USD | 195,000USD | 329,000USD | — |
| Gross Profit | -323,000USD | -258,000USD | 50,000,000USD | -329,000USD | — |
| Research Development | 51,522,000USD | 38,164,000USD | 27,603,000USD | 16,894,000USD | 22,360,000USD |
| Selling General Administrative | 16,537,000USD | 12,472,000USD | 6,320,000USD | 5,826,000USD | 6,287,000USD |
| Total Operating Expenses | 68,059,000USD | 50,636,000USD | 66,077,000USD | 22,720,000USD | 28,647,000USD |
| Operating Income | -68,059,000USD | -50,894,000USD | -16,077,000USD | -22,720,000USD | -28,647,000USD |
| Interest Income | 8,246,000USD | 8,905,000USD | 4,606,000USD | 761,000USD | 77,000USD |
| Net Interest Income | 8,246,000USD | 8,905,000USD | 4,398,000USD | 373,000USD | -255,000USD |
| Income Before Tax | -59,978,000USD | -42,258,000USD | 23,170,000USD | -24,253,000USD | -29,001,000USD |
| Net Income | -59,978,000USD | -42,258,000USD | 22,720,000USD | -24,253,000USD | -29,001,000USD |
| Net Income From Continuing Ops | -59,978,000USD | -42,258,000USD | 22,720,000USD | -24,253,000USD | -29,001,000USD |
| Ebit | -59,978,000USD | -42,258,000USD | 23,378,000USD | -23,865,000USD | -28,661,000USD |
| Ebitda | -59,655,000USD | -42,000,000USD | 23,573,000USD | -23,536,000USD | -28,336,000USD |
| Depreciation And Amortization | 323,000USD | 258,000USD | 195,000USD | 329,000USD | 325,000USD |
| Reconciled Depreciation | 323,000USD | 258,000USD | 195,000USD | 329,000USD | 325,000USD |
| Total Other Income Expense Net | 8,081,000USD | 8,636,000USD | 39,247,000USD | -1,533,000USD | -354,000USD |
| Interest Expense | — | 0USD | 208,000USD | 388,000USD | 332,000USD |
| Tax Provision | — | 0USD | 450,000USD | 0USD | — |
| Selling And Marketing Expenses | — | — | 195,000USD | 805,000USD | — |
| Unclassified Operating Expenses | — | — | 31,959,000USD | — | — |
| Income Tax Expense | — | — | 450,000USD | — | 241,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 250,367,000USD | 261,349,000USD | 276,642,000USD | 190,847,000USD | 182,888,000USD | 198,264,000USD | 212,847,000USD | 216,034,000USD |
| Cash And Equivalents | 14,711,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 236,551,000USD | 246,328,000USD | 262,896,000USD | 182,407,000USD | 175,484,000USD | 190,710,000USD | 204,760,000USD | 213,911,000USD |
| Short Term Investments | 221,840,000USD | 226,170,000USD | 187,293,000USD | 139,774,000USD | 154,700,000USD | 168,240,000USD | 182,817,000USD | 173,020,000USD |
| Total Current Assets | 242,580,000USD | 252,964,000USD | 267,917,000USD | 184,927,000USD | 176,839,000USD | 192,134,000USD | 206,388,000USD | 215,143,000USD |
| Other Current Assets | 6,029,000USD | 6,636,000USD | 5,021,000USD | 2,520,000USD | 1,355,000USD | 1,424,000USD | 1,628,000USD | 1,232,000USD |
| Other Non Current Assets | 364,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 10,707,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,526,000USD | 6,657,000USD | 9,744,000USD | 6,361,000USD | 7,214,000USD | 8,949,000USD | 9,974,000USD | 5,806,000USD |
| Other Current Liabilities | 3,628,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 239,660,000USD | 250,041,000USD | 260,989,000USD | 180,470,000USD | 171,390,000USD | 184,768,000USD | 198,066,000USD | 210,228,000USD |
| Total Equity Including Noncontrolling Interest | 239,660,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 7,423,000USD | 8,073,000USD | 8,469,000USD | 5,654,000USD | 5,863,000USD | 6,126,000USD | 6,456,000USD | 888,000USD |
| Accounts Payable | 505,000USD | 1,495,000USD | 1,016,000USD | 786,000USD | 2,001,000USD | 3,645,000USD | 1,811,000USD | 1,397,000USD |
| Short Term Debt | 2,393,000USD | 2,303,000USD | 2,341,000USD | 1,477,000USD | 1,466,000USD | 1,455,000USD | 1,452,000USD | 611,000USD |
| Retained Earnings | -206,990,000USD | -191,836,000USD | -177,380,000USD | -162,224,000USD | -149,432,000USD | -133,392,000USD | -117,402,000USD | -102,837,000USD |
| Accumulated Other Comprehensive Income | -573,000USD | -253,000USD | 260,000USD | 265,000USD | 147,000USD | 170,000USD | 71,000USD | 561,000USD |
| Total Liab | — | 11,308,000USD | 15,653,000USD | 10,377,000USD | 11,498,000USD | 13,496,000USD | 14,781,000USD | 5,806,000USD |
| Other Current Liab | — | 2,859,000USD | 6,387,000USD | 4,098,000USD | 3,747,000USD | 3,849,000USD | 6,746,000USD | 3,798,000USD |
| Common Stock | — | 37,000USD | 37,000USD | 29,000USD | 26,000USD | 26,000USD | 26,000USD | 26,000USD |
| Capital Stock | — | 37,000USD | 37,000USD | 29,000USD | 26,000USD | 26,000USD | 26,000USD | 26,000USD |
| Cash | — | 20,158,000USD | 75,603,000USD | 42,633,000USD | 20,784,000USD | 22,470,000USD | 21,943,000USD | 40,891,000USD |
| Net Debt | — | -13,204,000USD | -67,353,000USD | -37,140,000USD | -15,034,000USD | -16,468,000USD | -15,684,000USD | -40,280,000USD |
| Short Long Term Debt Total | — | 6,954,000USD | 8,250,000USD | 5,493,000USD | 5,750,000USD | 6,002,000USD | 6,259,000USD | 611,000USD |
| Property Plant Equipment Gross | — | 8,073,000USD | 10,432,000USD | 5,654,000USD | 5,863,000USD | 6,126,000USD | 8,173,000USD | 888,000USD |
| Common Stock Shares Outstanding | — | 37,339,026shares | 30,863,497shares | 28,115,548shares | 25,895,996shares | 25,868,935shares | 25,854,549shares | 25,736,076shares |
| Non Current Assets Total | — | 8,385,000USD | 8,725,000USD | 5,920,000USD | 6,049,000USD | 6,130,000USD | 6,459,000USD | 891,000USD |
| Non Current Liabilities Total | — | 4,651,000USD | 5,909,000USD | 4,016,000USD | 4,283,999USD | 4,547,000USD | 4,807,000USD | 0USD |
| Non Currrent Assets Other | — | 312,000USD | 256,000USD | 266,000USD | 186,000USD | 4,000USD | 3,000USD | 3,000USD |
| Net Working Capital | — | 246,307,000USD | 258,173,000USD | 178,566,000USD | 169,625,000USD | 183,185,000USD | 196,414,000USD | 209,337,000USD |
| Unclassified Non Current Liabilities | — | 4,651,000USD | 5,909,000USD | 4,016,000USD | 4,283,999USD | 4,547,000USD | 4,807,000USD | — |
| Unclassified Equity | — | 442,056,000USD | 438,035,000USD | 342,371,000USD | 320,623,000USD | 317,938,000USD | 315,345,000USD | 312,452,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 276,642,000USD | 212,847,000USD | 130,386,000USD | 50,636,000USD | 70,518,000USD |
| Other Current Assets | 5,021,000USD | 1,628,000USD | 2,516,000USD | 2,306,000USD | 1,550,000USD |
| Total Liab | 15,653,000USD | 14,781,000USD | 198,322,000USD | 11,366,000USD | 8,930,000USD |
| Total Stockholder Equity | 260,989,000USD | 198,066,000USD | -67,936,000USD | 39,270,000USD | 61,588,000USD |
| Other Current Liab | 6,387,000USD | 6,711,000USD | 4,385,000USD | 3,372,000USD | 1,764,000USD |
| Common Stock | 37,000USD | 26,000USD | 2,000USD | 12,000USD | 12,000USD |
| Capital Stock | 37,000USD | 26,000USD | 2,000USD | 2,000USD | 12,000USD |
| Retained Earnings | -177,380,000USD | -117,402,000USD | -75,144,000USD | -97,864,000USD | -73,611,000USD |
| Cash | 75,603,000USD | 21,943,000USD | 15,526,000USD | 5,569,000USD | 4,630,000USD |
| Cash And Short Term Investments | 262,896,000USD | 204,760,000USD | 125,190,000USD | 47,239,000USD | 69,004,000USD |
| Total Current Assets | 267,917,000USD | 206,388,000USD | 127,706,000USD | 48,392,000USD | 69,779,000USD |
| Total Current Liabilities | 9,744,000USD | 9,974,000USD | 5,484,000USD | 7,550,000USD | 3,674,000USD |
| Net Debt | -67,353,000USD | -15,684,000USD | 177,666,000USD | 280,000USD | 279,000USD |
| Short Term Debt | 2,341,000USD | 1,452,000USD | 464,000USD | 5,058,000USD | 1,250,000USD |
| Short Long Term Debt Total | 8,250,000USD | 6,259,000USD | 193,192,000USD | 5,849,000USD | 4,909,000USD |
| Short Term Investments | 187,293,000USD | 182,817,000USD | 109,664,000USD | 41,670,000USD | 64,373,999USD |
| Accounts Payable | 1,016,000USD | 1,811,000USD | 635,000USD | 430,000USD | 660,000USD |
| Property Plant Equipment Net | 8,469,000USD | 6,456,000USD | 1,397,000USD | 2,115,000USD | 642,000USD |
| Property Plant Equipment Gross | 10,432,000USD | 8,173,000USD | 2,874,000USD | 3,395,000USD | 1,602,000USD |
| Accumulated Other Comprehensive Income | 260,000USD | 71,000USD | 108,000USD | -76,000USD | -35,000USD |
| Common Stock Shares Outstanding | 27,700,855shares | 25,854,549shares | 25,130,790shares | 25,130,790shares | 25,130,790shares |
| Non Current Assets Total | 8,725,000USD | 6,459,000USD | 2,680,000USD | 2,244,000USD | 739,000USD |
| Non Current Liabilities Total | 5,909,000USD | 4,807,000USD | 192,838,000USD | 3,816,000USD | 5,256,000USD |
| Non Currrent Assets Other | 256,000USD | 3,000USD | 1,283,000USD | 129,000USD | 97,000USD |
| Net Working Capital | 258,173,000USD | 196,414,000USD | 122,222,000USD | 40,842,000USD | 66,105,000USD |
| Unclassified Non Current Liabilities | 5,909,000USD | 4,807,000USD | 192,728,000USD | — | — |
| Unclassified Equity | 438,035,000USD | 315,345,000USD | 7,096,000USD | 137,196,000USD | 135,210,000USD |
| Other Assets | — | — | 1USD | — | — |
| Non Current Liabilities Other | — | — | 110,000USD | 3,025,000USD | 1,597,000USD |
| Short Long Term Debt | — | — | — | 3,948,000USD | 1,250,000USD |
| Unclassified Current Assets | — | — | — | -1,153,000USD | — |
| Unclassified Current Liabilities | — | — | — | -5,258,000USD | -1,250,000USD |
| Long Term Debt | — | — | — | — | 3,659,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -14,456,000USD | -15,156,000USD | -12,792,000USD | -16,040,000USD | -15,990,000USD | -14,565,000USD | -10,267,000USD | -9,009,000USD |
| Depreciation | 83,000USD | 85,000USD | 81,000USD | 79,000USD | 78,000USD | 75,000USD | 62,000USD | 60,000USD |
| Stock Based Compensation | 3,823,000USD | 2,482,000USD | 2,569,000USD | 2,418,000USD | 2,569,000USD | 2,251,000USD | 2,291,000USD | 1,494,000USD |
| Other Non Cash Items | 231,000USD | 278,000USD | 237,000USD | -184,000USD | 13,000USD | -913,000USD | -573,000USD | 799,000USD |
| Change In Working Capital | -5,947,000USD | -731,000USD | -2,292,000USD | -1,934,000USD | -1,082,000USD | 2,950,000USD | 2,318,000USD | -209,000USD |
| Total Cash From Operating Activities | -16,266,000USD | -13,042,000USD | -12,197,000USD | -15,661,000USD | -14,412,000USD | -10,202,000USD | -6,169,000USD | -8,359,000USD |
| Capital Expenditures | -312,000USD | -42,000USD | -98,000USD | -44,000USD | -47,000USD | -166,000USD | -82,000USD | -119,000USD |
| Free Cash Flow | -16,578,000USD | -13,084,000USD | -12,295,000USD | -15,705,000USD | -14,459,000USD | -10,368,000USD | -6,251,000USD | -8,478,000USD |
| Investments | -38,996,000USD | -47,411,000USD | 14,941,000USD | 13,884,000USD | 14,915,000USD | -9,388,000USD | -30,183,000USD | -38,899,000USD |
| Total Cashflows From Investing Activities | -39,308,000USD | -47,453,000USD | 14,941,000USD | 13,884,000USD | 14,915,000USD | -9,388,000USD | -30,183,000USD | -38,899,000USD |
| Total Cash From Financing Activities | 129,000USD | 93,465,000USD | 19,105,000USD | 91,000USD | 24,000USD | 642,000USD | 13,000USD | 108,224,000USD |
| Change In Cash | -55,445,000USD | 32,970,000USD | 21,849,000USD | -1,686,000USD | 527,000USD | -18,948,000USD | -36,339,000USD | 60,966,000USD |
| Begin Period Cash Flow | 75,603,000USD | 42,633,000USD | 20,784,000USD | 22,470,000USD | 21,943,000USD | 40,891,000USD | 77,230,000USD | 16,264,000USD |
| End Period Cash Flow | 20,158,000USD | 75,603,000USD | 42,633,000USD | 20,784,000USD | 22,470,000USD | 21,943,000USD | 40,891,000USD | 77,230,000USD |
| Other Cashflows From Financing Activities | -69,000USD | 256,000USD | 93,000USD | -176,000USD | 24,000USD | 642,000USD | 13,000USD | 108,364,000USD |
| Issuance Of Capital Stock | — | 93,243,000USD | 19,012,000USD | — | — | 0USD | 0USD | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 20,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -1,494,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -59,978,000USD | -42,258,000USD | 22,720,000USD | -24,253,000USD | -29,001,000USD |
| Depreciation | 323,000USD | 258,000USD | 195,000USD | 329,000USD | 325,000USD |
| Stock Based Compensation | 10,038,000USD | 6,804,000USD | 2,219,000USD | 1,927,000USD | 1,749,000USD |
| Other Non Cash Items | 344,000USD | -2,983,000USD | -4,761,000USD | 3,143,000USD | 553,000USD |
| Change In Working Capital | -6,039,000USD | 5,334,000USD | -1,024,000USD | -1,267,000USD | 108,000USD |
| Total Cash From Operating Activities | -55,312,000USD | -32,845,000USD | 19,349,000USD | -20,121,000USD | -26,266,000USD |
| Capital Expenditures | -231,000USD | -514,000USD | -414,000USD | -118,000USD | -168,000USD |
| Free Cash Flow | -55,543,000USD | -33,359,000USD | 18,935,000USD | -20,239,000USD | -26,434,000USD |
| Investments | -3,482,000USD | -69,739,000USD | -65,568,000USD | 22,299,000USD | -64,968,000USD |
| Total Cashflows From Investing Activities | -3,713,000USD | -69,739,000USD | -65,568,000USD | 22,299,000USD | -64,968,000USD |
| Total Cash From Financing Activities | 112,685,000USD | 109,001,000USD | 56,176,000USD | -1,239,000USD | 79,839,000USD |
| Issuance Of Capital Stock | 112,255,000USD | 108,211,000USD | 60,138,000USD | 0USD | 79,726,000USD |
| Change In Cash | 53,660,000USD | 6,417,000USD | 9,957,000USD | 939,000USD | -11,395,000USD |
| Begin Period Cash Flow | 21,943,000USD | 15,526,000USD | 5,569,000USD | 4,630,000USD | 16,025,000USD |
| End Period Cash Flow | 75,603,000USD | 21,943,000USD | 15,526,000USD | 5,569,000USD | 4,630,000USD |
| Net Borrowings | — | 0USD | -3,750,000USD | -1,250,000USD | 0USD |
| Sale Purchase Of Stock | — | 0USD | -28,000USD | -4,000USD | 0USD |
| Other Cashflows From Investing Activities | — | 20,000USD | — | 22,417,000USD | -64,800,000USD |
| Other Cashflows From Financing Activities | — | 790,000USD | 59,954,000USD | 15,000USD | 79,839,000USD |
| Unclassified Financing Cash Flow | — | 108,211,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | -22,299,000USD | 64,968,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.